-
The Long-Term Cost-Effectiveness of Insulin Icodec vs. Once-Daily Basal Insulin Analogs in Italy
Sep 9, 2025, 16:22 PM -
Cost Effectiveness and Budget Impact Analysis of Benralizumab for Treating Severe Uncontrolled Eosinophilic Asthma in Egypt
Sep 9, 2025, 16:22 PM -
Informing the Sustainable Development of Novel Therapies Using Value-Based Real Options Analysis
Sep 9, 2025, 16:22 PM -
Budget Impact Minimization Approaches Used Across Europe, Brazil, and Japan in the Reimbursement of Obesity Medications
Sep 9, 2025, 16:22 PM -
Economic Evaluation of a Booster Dose of TDaP Vaccine to Adolescents in Spain
Sep 9, 2025, 16:22 PM -
Early Adoption of New Combination Biologic Therapy Enabled by Enhanced Diagnostic Accuracy in Inflammatory Bowel Disease (IBD) Can Be a Budget-Neutral Approach: A Budget Impact Analysis in Italy
Sep 9, 2025, 16:22 PM -
Persistence With Osteoporosis Medication Treatments Among Chinese Patients With Osteoporosis: A Retrospective Cohort Study
Sep 9, 2025, 16:22 PM -
Comparative Effectiveness of Second-Line Antidiabetic Medications on the Risk of Major Adverse Cardiovascular Events: A Real-World Study in China
Sep 9, 2025, 16:22 PM -
How Can Intravitreal Aflibercept 8 mg Impact Treatment Burden and Costs in European Patients With Diabetic Macular Edema? From Clinical Trials to Clinical Practice
Sep 9, 2025, 16:22 PM -
Impact of Resmetirom on Liver Transplant Demand and Outcomes in US Patients With MASH
Sep 9, 2025, 16:22 PM -
What Has Worked Well in Fabry Disease? An HTA Landscape Assessment Study
Sep 9, 2025, 16:22 PM -
Economic Impact of Poison Control Center Interventions on Hospitalization Costs in Algeria: A Retrospective Analysis
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Multiplex Cell Culture Technology for Predicting Carboplatin Plus Paclitaxel-Induced Side Effects in Cancer Care
Sep 9, 2025, 16:22 PM -
Beyond the Conversation: A Narrative Review of Cost-Informed Shared Decision Making and Its Impact on Medication Adherence in Chronic Conditions
Sep 9, 2025, 16:22 PM -
Economic Evaluation of I-Medicine: An AI-Driven E-Medicine Platform for Reducing Adverse Drug Reactions and Healthcare Expenditures
Sep 9, 2025, 16:22 PM -
Comparative Efficacy of Iptacopan Monotherapy vs. Danicopan Add-on to C5i in Paroxysmal Nocturnal Hemoglobinuria (PNH) Results From an Indirect Treatment Comparison (ITC)
Sep 9, 2025, 16:22 PM -
Real-World Cost of Automated Red Blood Cell Exchange for Sickle Cell Disease in Kenya: A Cost-Reimbursement Gap Analysis From a Public Sector Perspective
Sep 9, 2025, 16:22 PM -
Enhancing Healthcare Cost Communication Through Visualization: A Decision Tree Framework
Sep 9, 2025, 16:22 PM -
Have Delays in Vaccine Market Access Improved in Europe and the US Over the Last Decade?
Sep 9, 2025, 16:22 PM -
Grounded Theory Study to Assess Barriers and Reasons for Insufficient Compliance With Valproate Risk Minimization Measures: Example of a Qualitative Method Aligned With the Recommendations of the GVP Module XVI, Addendum II
Sep 9, 2025, 16:22 PM
